APA (7th ed.) Citation

D, T., MA, M., J, B., A, B., K, R. T., I, P., . . . J, L. (2022). Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes. Immunotherapy advances, 2(1), ltac002. https://doi.org/10.1093/immadv/ltac002

Chicago Style (17th ed.) Citation

D, Tatovic, et al. "Safety of the Use of Gold Nanoparticles Conjugated with Proinsulin Peptide and Administered by Hollow Microneedles as an Immunotherapy in Type 1 Diabetes." Immunotherapy Advances 2, no. 1 (2022): ltac002. https://doi.org/10.1093/immadv/ltac002.

MLA (9th ed.) Citation

D, Tatovic, et al. "Safety of the Use of Gold Nanoparticles Conjugated with Proinsulin Peptide and Administered by Hollow Microneedles as an Immunotherapy in Type 1 Diabetes." Immunotherapy Advances, vol. 2, no. 1, 2022, p. ltac002, https://doi.org/10.1093/immadv/ltac002.